Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians

Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modifications. Aim and Objectives: To evaluate the effectiveness of Diabefly(®) digital therapeutics platform for glycemic control among people with type 2 diabetes. Results: De-identified data of 144 participants referred by physicians (mean age: 46.42 years, 54.54 % females) on the 90 days Diabefly(®) program was analyzed. A mean significant reduction in HbA1C was observed by 1.56% (P< 0.001) from baseline 8.59%. Similarly, mean weight and BMI significantly reduced by 2.39 kg and 0.84 kg/m(2) (P<0.001 for both) from a baseline of 75.63 kg and 27.34 kg/m(2) respectively. Complete FBS and PPBS readings were provided by 56 and 39 participants respectively. A mean reduction in FBS and PPBS was observed by 53.93 mg/dL and 99.25 mg/dl (P < 0.001 for both) from a baseline of 168.2 mg/dL and 234.7 mg/dl respectively. Conclusion: Significant reduction in HbA1c, weight, BMI, FBS and PPBS was observed after participation in the Diabefly(®) program. The study thus showed significant improvement in glycemic control in people with diabetes after participation.